Search

Gollamudi S. Kishore

Examiner (ID: 18204, Phone: (571)272-0598 , Office: P/1612 )

Most Active Art Unit
1612
Art Unit(s)
1502, 1503, 1612, 2899, 1615
Total Applications
3055
Issued Applications
1377
Pending Applications
265
Abandoned Applications
1411

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 16776390 [patent_doc_number] => 20210113467 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-04-22 [patent_title] => METHODS FOR THE MANUFACTURE OF LIPOSOMAL DRUG FORMULATIONS [patent_app_type] => utility [patent_app_number] => 17/052070 [patent_app_country] => US [patent_app_date] => 2019-05-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6093 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -34 [patent_words_short_claim] => 104 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17052070 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/052070
METHODS FOR THE MANUFACTURE OF LIPOSOMAL DRUG FORMULATIONS May 1, 2019 Abandoned
Array ( [id] => 16913786 [patent_doc_number] => 20210186878 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-06-24 [patent_title] => MULTI-VESICULAR LIPOSOMES FOR TARGETED DELIVERY OF DRUGS AND BIOLOGICS FOR TISSUE ENGINEERING [patent_app_type] => utility [patent_app_number] => 17/050556 [patent_app_country] => US [patent_app_date] => 2019-04-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7292 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -23 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17050556 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/050556
Multi-vesicular liposomes for targeted delivery of drugs and biologics for tissue engineering Apr 28, 2019 Issued
Array ( [id] => 18084292 [patent_doc_number] => 11534399 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-12-27 [patent_title] => Inhalable liposomal sustained release composition for use in treating pulmonary diseases [patent_app_type] => utility [patent_app_number] => 17/045940 [patent_app_country] => US [patent_app_date] => 2019-04-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 8063 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 91 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17045940 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/045940
Inhalable liposomal sustained release composition for use in treating pulmonary diseases Apr 22, 2019 Issued
Array ( [id] => 14712447 [patent_doc_number] => 20190247287 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-08-15 [patent_title] => COMPOSITIONS AND METHODS FOR IMPROVED SKIN CARE [patent_app_type] => utility [patent_app_number] => 16/390604 [patent_app_country] => US [patent_app_date] => 2019-04-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16809 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16390604 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/390604
COMPOSITIONS AND METHODS FOR IMPROVED SKIN CARE Apr 21, 2019 Abandoned
Array ( [id] => 17050533 [patent_doc_number] => 20210259967 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-08-26 [patent_title] => TREATMENT OF SEPSIS AND SEPTIC SHOCK [patent_app_type] => utility [patent_app_number] => 17/048909 [patent_app_country] => US [patent_app_date] => 2019-04-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10657 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17048909 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/048909
TREATMENT OF SEPSIS AND SEPTIC SHOCK Apr 17, 2019 Abandoned
Array ( [id] => 17814300 [patent_doc_number] => 11419887 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-08-23 [patent_title] => Vehicle for delivering a compound to a mucous membrane and related compositions, methods and systems [patent_app_type] => utility [patent_app_number] => 16/386522 [patent_app_country] => US [patent_app_date] => 2019-04-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 27 [patent_no_of_words] => 16373 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 79 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16386522 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/386522
Vehicle for delivering a compound to a mucous membrane and related compositions, methods and systems Apr 16, 2019 Issued
Array ( [id] => 16612024 [patent_doc_number] => 20210030677 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-02-04 [patent_title] => TREATMENT OF PNEUMONIA [patent_app_type] => utility [patent_app_number] => 17/047666 [patent_app_country] => US [patent_app_date] => 2019-04-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9309 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -21 [patent_words_short_claim] => 100 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17047666 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/047666
Treatment of pneumonia Apr 15, 2019 Issued
Array ( [id] => 16761017 [patent_doc_number] => 20210106598 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-04-15 [patent_title] => PHYTATES FOR USE AS A BIOMOLECULES DELIVERY OR ADSORPTION SYSTEM [patent_app_type] => utility [patent_app_number] => 17/044768 [patent_app_country] => US [patent_app_date] => 2019-04-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6321 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -13 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17044768 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/044768
Phytates for use as a biomolecules delivery or adsorption system Apr 9, 2019 Issued
Array ( [id] => 15114267 [patent_doc_number] => 20190343766 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-11-14 [patent_title] => MEDICAL USE OF SPLA2 HYDROLYSABLE LIPOSOMES [patent_app_type] => utility [patent_app_number] => 16/360836 [patent_app_country] => US [patent_app_date] => 2019-03-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8072 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16360836 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/360836
Medical use of sPLA2 hydrolysable liposomes Mar 20, 2019 Issued
Array ( [id] => 14833201 [patent_doc_number] => 20190275001 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-09-12 [patent_title] => SUNITINIB FORMULATIONS AND METHODS FOR USE THEREOF IN TREATMENT OF OCULAR DISORDERS [patent_app_type] => utility [patent_app_number] => 16/357195 [patent_app_country] => US [patent_app_date] => 2019-03-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21397 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -26 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16357195 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/357195
SUNITINIB FORMULATIONS AND METHODS FOR USE THEREOF IN TREATMENT OF OCULAR DISORDERS Mar 17, 2019 Abandoned
Array ( [id] => 14531827 [patent_doc_number] => 20190201534 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-07-04 [patent_title] => SUSTAINED RELEASE OF ANTIINFECTIVES [patent_app_type] => utility [patent_app_number] => 16/297027 [patent_app_country] => US [patent_app_date] => 2019-03-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18834 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -85 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16297027 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/297027
SUSTAINED RELEASE OF ANTIINFECTIVES Mar 7, 2019 Abandoned
Array ( [id] => 18328144 [patent_doc_number] => 11633357 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-04-25 [patent_title] => Liposome formulation and manufacture [patent_app_type] => utility [patent_app_number] => 16/289775 [patent_app_country] => US [patent_app_date] => 2019-03-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 6 [patent_no_of_words] => 10551 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 63 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16289775 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/289775
Liposome formulation and manufacture Feb 28, 2019 Issued
Array ( [id] => 15035321 [patent_doc_number] => 20190328665 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-10-31 [patent_title] => LIPOSOME COMPOSITIONS ENCAPSULATING MODIFIED CYCLODEXTRIN COMPLEXES AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 16/288826 [patent_app_country] => US [patent_app_date] => 2019-02-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15511 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16288826 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/288826
LIPOSOME COMPOSITIONS ENCAPSULATING MODIFIED CYCLODEXTRIN COMPLEXES AND USES THEREOF Feb 27, 2019 Abandoned
Array ( [id] => 18947079 [patent_doc_number] => 11890352 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-02-06 [patent_title] => Plectin-targeted liposomes/PARP inhibitor in the treatment of cancer [patent_app_type] => utility [patent_app_number] => 16/971095 [patent_app_country] => US [patent_app_date] => 2019-02-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 26 [patent_no_of_words] => 23151 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16971095 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/971095
Plectin-targeted liposomes/PARP inhibitor in the treatment of cancer Feb 26, 2019 Issued
Array ( [id] => 16466637 [patent_doc_number] => 20200368174 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-11-26 [patent_title] => PARTICLES FOR TARGETED DELIVERY OF ACTIVE AGENTS INTO ADIPOSE STROMAL CELLS [patent_app_type] => utility [patent_app_number] => 16/966310 [patent_app_country] => US [patent_app_date] => 2019-02-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21291 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -24 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16966310 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/966310
PARTICLES FOR TARGETED DELIVERY OF ACTIVE AGENTS INTO ADIPOSE STROMAL CELLS Feb 20, 2019 Abandoned
Array ( [id] => 16776403 [patent_doc_number] => 20210113480 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-04-22 [patent_title] => COMPOSITION FOR INCREASING EXPRESSION OF BLOOD COAGULATION FACTOR GENE, COMPRISING CORE-SHELL STRUCTURED MICROPARTICLES AS ACTIVE INGREDIENT [patent_app_type] => utility [patent_app_number] => 16/969040 [patent_app_country] => US [patent_app_date] => 2019-02-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5748 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 73 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16969040 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/969040
COMPOSITION FOR INCREASING EXPRESSION OF BLOOD COAGULATION FACTOR GENE, COMPRISING CORE-SHELL STRUCTURED MICROPARTICLES AS ACTIVE INGREDIENT Feb 11, 2019 Abandoned
Array ( [id] => 14403391 [patent_doc_number] => 20190167539 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-06-06 [patent_title] => DMS (derma membrane structure) in Foam Creams [patent_app_type] => utility [patent_app_number] => 16/270929 [patent_app_country] => US [patent_app_date] => 2019-02-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7417 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -31 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16270929 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/270929
DMS (derma membrane structure) in Foam Creams Feb 7, 2019 Abandoned
Array ( [id] => 14372349 [patent_doc_number] => 20190160087 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-05-30 [patent_title] => SUSTAINED RELEASE OF ANTIINFECTIVES [patent_app_type] => utility [patent_app_number] => 16/264865 [patent_app_country] => US [patent_app_date] => 2019-02-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7781 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -23 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16264865 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/264865
SUSTAINED RELEASE OF ANTIINFECTIVES Jan 31, 2019 Abandoned
Array ( [id] => 14338541 [patent_doc_number] => 20190151243 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-05-23 [patent_title] => COMPOSITION OF MATTER COMPRISING LIPOSOMES EMBEDDED IN A POLYMERIC MATRIX AND METHODS OF USING SAME [patent_app_type] => utility [patent_app_number] => 16/254084 [patent_app_country] => US [patent_app_date] => 2019-01-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21203 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 164 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16254084 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/254084
Composition of matter comprising liposomes embedded in a polymeric matrix and methods of using same Jan 21, 2019 Issued
Array ( [id] => 18215167 [patent_doc_number] => 11590079 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-02-28 [patent_title] => Treating microvascular dysfunction [patent_app_type] => utility [patent_app_number] => 16/962956 [patent_app_country] => US [patent_app_date] => 2019-01-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 12 [patent_no_of_words] => 15397 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 85 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16962956 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/962956
Treating microvascular dysfunction Jan 17, 2019 Issued
Menu